Skip to content

Creation of a Bank of Biological Materials and Associated Data Related to Patients With Infectious and Tropical Diseases

Creation of a Bank of Biological Materials and Associated Data Related to Patients With Infectious and Tropical Diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05770765
Acronym
TropicaBiobank
Enrollment
60000
Registered
2023-03-15
Start date
2019-10-30
Completion date
2059-10-30
Last updated
2023-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infections

Brief summary

This is the protocol that formalizes the establishment of the TROPICA-BIOBANK biobank

Detailed description

Subjects who will access the Department of Infectious and Tropical Diseases for investigations, analyzes or visits on suspicion of infectious or tropical disease, hospitalized patients and/or patients participating in proposed clinical trials from the Department will be enrolled. Healthy volunteer donors may also be enrolled. The type of samples collected and stored in the biobank consists of human biological matrices liquids and solids, DNA, protein extracts or subcellular fractions, bacterial isolates and arthropods taken from patients. The collection of samples takes place through the support of various professional figures (doctor, nurse, laboratory technician, biologist/biotechnologist) together with associated data. The samples are de-identified and protected by an encryption system (through the system computer diagnostic data management of the laboratory of the IRCCS Sacro Cuore Don Calabria) and stored at a temperature of -80°C, in the Department's freezers. Samples are stored for 40 years. In order to monitor the quality of the samples over the storage time, a selection of samples used as monthly analytical quality controls will be retested periodically (every 10 years). At the end of the storage time, it will be evaluated whether to extend the storage time of the unused biological samples and associated data or if these will be destroyed. In the first case, an amendment to this Protocol will be submitted to the CESC for approval, in which will specify the duration of the extension of the conservation of the samples and associated data. In the second case, no further data will be collected on the aforementioned samples, without prejudice to their use of those possibly already collected to determine, without altering them, the results of searches already in progress. The samples will in any case be destroyed if they are not in good condition.

Interventions

None listed

Sponsors

IRCCS Sacro Cuore Don Calabria di Negrar
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

• Informed consent (for healthy volounteers also: age \> 18 years, health status ascertained by laboratory tests, electrocardiogram and medical examination)

Exclusion criteria

* History of alcohol/drug abuse * Pregnant or breastfeeding women, unless there are justified and documented needs

Design outcomes

Primary

MeasureTime frameDescription
Presence of a viral, bacterial or parasitic pathogen40 yearsResult of laboratory tests on the pathogen responsible for the disease of interest

Countries

Italy

Contacts

Primary ContactElvia Malo
ricerca.clinica@sacrocuore.it+390456014854

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026